The present invention relates to a vaccine formulation for intranasal or inhalation administration, and to the preparation thereof, which formulation contains antigenic material freely mixed with empty liposomes....http://www.google.fr/patents/US5756104?utm_source=gb-gplus-shareBrevet US5756104 - Liposome-containing intranasal vaccine formulation